Skip to main content
. 2022 Sep 1;8(11):1571–1578. doi: 10.1001/jamaoncol.2022.3829

Figure 1. Kaplan-Meier Analysis of Survival in the Intention-to-Treat Population.

Figure 1.

P values based on log rank test stratified by lymph node status, resection margins, and postoperative CA 19-9. mFOLFIRINOX indicates modified fluorouracil, leucovorin, irinotecan, and oxaliplatin; sHR, stratified hazard ratio.